These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34560087)

  • 1. A PHF1-TFE3 fusion atypical ossifying fibromyxoid tumor with prominent collagenous rosettes: Case report with a brief review.
    Zou C; Ru GQ; Zhao M
    Exp Mol Pathol; 2021 Dec; 123():104686. PubMed ID: 34560087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel recurrent PHF1-TFE3 fusions in ossifying fibromyxoid tumors.
    Suurmeijer AJH; Song W; Sung YS; Zhang L; Swanson D; Fletcher CDM; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2019 Sep; 58(9):643-649. PubMed ID: 30920708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial malignant ossifying fibromyxoid tumors harboring the rare and recently described ZC3H7B-BCOR and PHF1-TFE3 fusions.
    Linos K; Kerr DA; Baker M; Wong S; Henderson E; Sumegi J; Bridge JA
    J Cutan Pathol; 2020 Oct; 47(10):934-945. PubMed ID: 32352579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Round cell tumor with a myxoid matrix harboring a PHF1-TFE3 fusion: Myoepithelial neoplasm or ossifying fibromyxoid tumor?
    Fei F; Prieto Granada CN; Harada S; Siegal GP; Wei S
    Pathol Res Pract; 2021 Sep; 225():153578. PubMed ID: 34391181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells.
    Hofvander J; Jo VY; Fletcher CDM; Puls F; Flucke U; Nilsson J; Magnusson L; Mertens F
    Mod Pathol; 2020 Jul; 33(7):1331-1340. PubMed ID: 31932680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors.
    Gebre-Medhin S; Nord KH; Möller E; Mandahl N; Magnusson L; Nilsson J; Jo VY; Vult von Steyern F; Brosjö O; Larsson O; Domanski HA; Sciot R; Debiec-Rychter M; Fletcher CD; Mertens F
    Am J Pathol; 2012 Sep; 181(3):1069-77. PubMed ID: 22796436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary malignant ossifying fibromyxoid tumour of the bone. A clinicopathologic and molecular report of two cases.
    Sbaraglia M; Bellan E; Gambarotti M; Righi A; Zanatta L; Toffolatti L; Dei Tos AP
    Pathologica; 2020 Dec; 112(4):184-190. PubMed ID: 33179613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.
    Kao YC; Sung YS; Zhang L; Chen CL; Huang SC; Antonescu CR
    Genes Chromosomes Cancer; 2017 Jan; 56(1):42-50. PubMed ID: 27537276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHF1 rearrangements in ossifying fibromyxoid tumors of soft parts: A fluorescence in situ hybridization study of 41 cases with emphasis on the malignant variant.
    Graham RP; Weiss SW; Sukov WR; Goldblum JR; Billings SD; Dotlic S; Folpe AL
    Am J Surg Pathol; 2013 Nov; 37(11):1751-5. PubMed ID: 23887158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHF1::TFE3-positive fibromyxoid sarcoma? Report of 2 cases and review of 13 cases of PHF1::TFE3-positive ossifying fibromyxoid tumor in the literature.
    Wei S; Patchefsky AS; Pei J; Brown SA; Basu Mallick A; Wang Z; Jiang W
    Am J Clin Pathol; 2024 Sep; ():. PubMed ID: 39250713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the molecular signatures of malignant ossifying fibromyxoid tumours with two novel gene fusions: PHF1::FOXR1 and PHF1::FOXR2.
    Srivastava P; Zilla ML; Naous R; Marker D; Khoshnoodi P; Burgess M; Herradura A; Wu J; Surrey LF; John I
    Histopathology; 2023 May; 82(6):946-952. PubMed ID: 36648026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ossifying Fibromyxoid Tumor of the Genitourinary Tract: Report of 4 Molecularly Confirmed Cases of a Diagnostic Pitfall.
    Argani P; Dickson BC; Gross JM; Matoso A; Baraban E; Antonescu CR
    Am J Surg Pathol; 2023 Jun; 47(6):709-716. PubMed ID: 37026814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ossifying fibromyxoid tumor: morphology, genetics, and differential diagnosis.
    Schneider N; Fisher C; Thway K
    Ann Diagn Pathol; 2016 Feb; 20():52-8. PubMed ID: 26732302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion of the Genes
    Panagopoulos I; Gorunova L; Lund-Iversen M; Bassarova A; Heim S
    Cancer Genomics Proteomics; 2019; 16(5):345-351. PubMed ID: 31467228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When molecular outsmarts morphology: Malignant ossifying fibromyxoid tumors masquerading as osteosarcomas, including a novel CREBZF::PHF1 fusion.
    Sharma AE; Dermawan JK; Sherrod AE; Chopra S; Maki RG; Antonescu CR
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23206. PubMed ID: 37819540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ossifying fibromyxoid tumor presenting EP400-PHF1 fusion gene.
    Endo M; Kohashi K; Yamamoto H; Ishii T; Yoshida T; Matsunobu T; Iwamoto Y; Oda Y
    Hum Pathol; 2013 Nov; 44(11):2603-8. PubMed ID: 23806526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A YAP1::TFE3 cutaneous low-grade fibromyxoid neoplasm: A novel entity!
    Patton A; Bridge JA; Liebner D; Chung C; Iwenofu OH
    Genes Chromosomes Cancer; 2022 Apr; 61(4):194-199. PubMed ID: 34874592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ossifying fibromyxoid tumor: a study of 6 cases of atypical and malignant variants.
    Dantey K; Schoedel K; Yergiyev O; McGough R; Palekar A; Rao UNM
    Hum Pathol; 2017 Feb; 60():174-179. PubMed ID: 27816723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors--molecular characterization shows genetic overlap with endometrial stromal sarcoma.
    Antonescu CR; Sung YS; Chen CL; Zhang L; Chen HW; Singer S; Agaram NP; Sboner A; Fletcher CD
    Genes Chromosomes Cancer; 2014 Feb; 53(2):183-93. PubMed ID: 24285434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ossifying fibromyxoid tumor: a clinicopathologic analysis of 26 subcutaneous tumors with emphasis on differential diagnosis and prognostic factors.
    Atanaskova Mesinkovska N; Buehler D; McClain CM; Rubin BP; Goldblum JR; Billings SD
    J Cutan Pathol; 2015 Sep; 42(9):622-31. PubMed ID: 25950586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.